Blood Pressure Management for 74-Year-Old Hispanic Male on Amlodipine 5mg
Add a thiazide-like diuretic (chlorthalidone or indapamide) or an ACE inhibitor/ARB to the current amlodipine 5mg to achieve the target blood pressure of <130/80 mmHg. 1
Treatment Algorithm
Step 1: Confirm Uncontrolled Hypertension
- Verify BP is ≥130/80 mmHg using out-of-office measurements (home BP monitoring or ambulatory BP monitoring) if possible 1
- Office BP alone can be used but out-of-office confirmation is strongly preferred
Step 2: Optimize Current Therapy with Combination Treatment
The patient is currently on suboptimal monotherapy. Current guidelines universally recommend combination therapy as initial treatment for confirmed hypertension (BP ≥140/90 mmHg), and this patient on amlodipine 5mg alone represents undertreated hypertension 1.
Preferred options (in order):
Add a RAS blocker (ACE inhibitor or ARB) to amlodipine 5mg
Add a thiazide-like diuretic (chlorthalidone or indapamide, NOT hydrochlorothiazide)
- Alternative if RAS blocker contraindicated
- Creates CCB + diuretic combination 1
Do NOT simply increase amlodipine to 10mg as monotherapy - while FDA-approved 3, this approach is inferior to adding a second agent from a different class 1, 2
Step 3: Target Blood Pressure
Target: 120-129 mmHg systolic (if well tolerated) 1
- The 2024 ESC guidelines recommend treating to 120-129 mmHg systolic in most adults
- The 2025 AHA/ACC guidelines specify <130/80 mmHg 4
- For this 74-year-old, aim for 120-129 mmHg systolic unless poorly tolerated, then use "as low as reasonably achievable" (ALARA principle) 1
Step 4: If BP Still Uncontrolled on Two Drugs
Escalate to three-drug combination:
- RAS blocker + amlodipine + thiazide-like diuretic (chlorthalidone or indapamide) 1
- Preferably as a single-pill combination 1
Step 5: If BP Still Uncontrolled on Three Drugs (Resistant Hypertension)
This defines resistant hypertension - BP uncontrolled despite optimal doses of three first-line agents including a diuretic 4
Required actions:
- Screen for secondary causes of hypertension 4
- Review ALL medications - remove interfering agents (NSAIDs, decongestants, etc.) 4
- Add spironolactone (mineralocorticoid receptor antagonist) if eGFR ≥45 mL/min/1.73 m² 4, 1
- If spironolactone not tolerated: consider eplerenone, beta-blocker, alpha-blocker, or central sympatholytic 4, 1
Special Considerations for This Patient
Age (74 years)
- Continue treatment lifelong even beyond age 85 if well tolerated 1
- Elderly patients show excellent response to amlodipine 5
- May start RAS blocker at lower dose but uptitrate to standard doses
- Monitor for orthostatic hypotension
Hispanic Ethnicity
- When provided access to comprehensive care, Hispanic patients demonstrate similar response rates to treatment as non-Hispanic whites 6
- Hispanic populations have high hypertension burden with substantial variation by heritage group 7
- Approximately 50% of Hispanic adults develop hypertension over 12 years, with only 34.7% achieving BP control when treated 7
- This emphasizes the critical importance of aggressive, guideline-directed combination therapy in this population
Dosing Specifics
- Amlodipine: Continue 5mg daily (can increase to 10mg if needed, but only as part of combination therapy) 3
- Timing: Take at most convenient time of day to establish routine and improve adherence 1
- Follow-up: See patient every 1-3 months until BP controlled, preferably within 3 months 1
Common Pitfalls to Avoid
- Clinical inertia - Don't leave patient on inadequate monotherapy 4
- Using hydrochlorothiazide instead of chlorthalidone/indapamide - thiazide-LIKE diuretics are superior 1
- Combining two RAS blockers (ACE inhibitor + ARB) - this is contraindicated 1
- Ignoring medication interference - NSAIDs and other drugs can elevate BP 4
- Inadequate dose titration - ensure optimal doses before declaring resistance 4
Monitoring
- Recheck BP in 7-14 days after medication adjustment (can be sooner if clinically warranted) 3
- Use out-of-office BP monitoring when possible
- Assess adherence at each visit
- Monitor renal function and electrolytes when adding RAS blocker or diuretic
- Screen for adverse effects (peripheral edema with amlodipine, hyperkalemia with RAS blockers/spironolactone, hypokalemia with thiazides)